Mike Mensinger, Chief Product Officer at Beta Bionics, Inc. (BBNX), sold 2,650 shares at $22.00 ($58K) on 2026-09-16, disclosed to the SEC on 2026-09-17.
Scheduled sale ($58k) by Chief Product Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| BBNX | SELL | 2026-03-03 | $13K | — | Filing → |
| BBNX | SELL | 2026-01-07 | $66K | — | Filing → |
| BBNX | SELL | 2026-01-05 | $231K | — | Filing → |